New research suggests that looking at structures in the right side of the brain may help predict who will better recover from language problems after a stroke.

A new University of Alberta study shows that vibrating the spine may reveal more than magnetic resonance imaging (MRI) when it comes to treating back pain.

A prospective study examining a trimodality treatment approach in localized bladder cancer cases using adaptive image-guided, intensity-modulated radiation therapy (IG-IMRT) found the bladder preservation rate at three years was 83 percent.

March 30, 2016 — The U.S. Food and Drug Administration (FDA) revoked the Mammography Quality Standards Act (MQSA) certificate of J. Bruce Jacobs M.D. Inc., doing business as Huntington Radiology in Huntington Park, Calif., on March 4. The FDA is alerting patients who had mammograms at the facility any time on or after Sept. 8, 2014, about possible problems with the quality of their mammograms.

This facility was the subject of a prior FDA Safety Notification issued on March 10, 2011.

MicroRNA molecules were discovered only relatively recently in humans, but have been shown to play a pivotal role in how a cell responds to injury or stress, such as radiation therapy. A University of California Los Angeles (UCLA)-led study has for the first time shown that microRNAs, specifically the microRNA known as miR-34, can sit silently in an inactive state in a cell waiting for a signal to turn it on.

March 30, 2016 — IBA (Ion Beam Applications SA) announced it has signed a contract with the University Hospitals Leuven (UZ Leuven) and Katholieke Universiteit Leuven (KU Leuven) to install Belgium’s first proton therapy center. The project will be conducted in collaboration with Université Catholique de Louvain (UCL), Cliniques universitaires Saint-Luc and other Belgian universities. IBA was awarded the contract following a comprehensive European public tender conducted by UZ Leuven.

March 30, 2016 — Diffusion tensor imaging (DTI), a type of magnetic resonance imaging (MRI), may be able to predict functional post-deployment outcomes for veterans who sustained mild traumatic brain injury (MTBI), or concussion, during combat, according to a new study published in the journal Radiology.

March 30, 2016 — Philips Healthcare introduced the first commercially available magnetic resonance (MR)-only simulation solution indicated for prostate cancer radiation oncology treatment planning in the United States. Philips has achieved 510(k) clearance from the Food and Drug Administration (FDA) for its MRCAT (Magnetic Resonance for Calculating ATtenuation) solution as part of its Ingenia MR-RT platform.

Choosing ongoing monitoring instead of immediate curative treatment (surgery or radiotherapy) leads to a better overall quality of life for men with low-risk prostate cancer.

A promising new discovery by University of California Los Angeles (UCLA) scientists could lead to a new method of identifying cancer patients that express high levels of an enzyme and are more likely to respond to cancer treatments.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now